NCT04879329 2026-01-07A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Seagen Inc.Phase 2 Recruiting372 enrolled
NCT05016973 2021-08-23A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2 Unknown25 enrolled